• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ganciclovir-resistant cytomegalovirus infection in renal transplantation.

作者信息

Vaz Raquel, Barros Francisca, Tavares Isabel, Bustorff Manuela, Ferreira Inês, Pestana Manuel

机构信息

Nephrology and Infectious Diseases Research and Development Group , INEB, University of Porto , Porto , Portugal ; Department of Nephrology , São João Hospital Center , Porto , Portugal.

Department of Nephrology , São João Hospital Center , Porto , Portugal.

出版信息

Clin Kidney J. 2014 Apr;7(2):210-3. doi: 10.1093/ckj/sfu005. Epub 2014 Feb 10.

DOI:10.1093/ckj/sfu005
PMID:25852874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4377781/
Abstract
摘要

相似文献

1
Ganciclovir-resistant cytomegalovirus infection in renal transplantation.肾移植中耐更昔洛韦的巨细胞病毒感染
Clin Kidney J. 2014 Apr;7(2):210-3. doi: 10.1093/ckj/sfu005. Epub 2014 Feb 10.
2
Update in management of ganciclovir-resistant cytomegalovirus infection.更昔洛韦耐药性巨细胞病毒感染的治疗进展
Curr Opin Infect Dis. 2008 Aug;21(4):433-7. doi: 10.1097/QCO.0b013e328307c7b4.
3
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.实体器官移植受者中耐更昔洛韦巨细胞病毒疾病的出现。
Lancet. 2000 Aug 19;356(9230):645-9. doi: 10.1016/S0140-6736(00)02607-6.
4
[Strains of ganciclovir-resistant cytomegalovirus].耐更昔洛韦的巨细胞病毒毒株
Enferm Infecc Microbiol Clin. 1999 Aug-Sep;17(7):330-4.
5
Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review.成功运用低剂量来氟米特治疗肾移植中对更昔洛韦耐药且伴有高水平抗原血症的巨细胞病毒感染：一例报告及文献综述
J Clin Virol. 2016 Sep;82:133-138. doi: 10.1016/j.jcv.2016.07.015. Epub 2016 Jul 27.
6
Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.由于UL97基因第595 - 596密码子处的联合缺失突变导致的耐更昔洛韦移植后巨细胞病毒感染。
Transpl Infect Dis. 2019 Dec;21(6):e13168. doi: 10.1111/tid.13168. Epub 2019 Sep 18.
7
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.肺移植受者中耐更昔洛韦巨细胞病毒感染的单中心经验：治疗与转归
J Heart Lung Transplant. 2007 Dec;26(12):1286-92. doi: 10.1016/j.healun.2007.09.012. Epub 2007 Nov 19.
8
Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients.肺移植受者中耐更昔洛韦巨细胞病毒的出现。
J Heart Lung Transplant. 2002 Dec;21(12):1274-82. doi: 10.1016/s1053-2498(02)00463-1.
9
Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.肺移植受者中更昔洛韦（GCV）治疗水平不足及对GCV耐药的巨细胞病毒情况
Transpl Infect Dis. 2014 Dec;16(6):941-50. doi: 10.1111/tid.12317. Epub 2014 Dec 10.
10
Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.更昔洛韦。其在预防移植受者巨细胞病毒感染和疾病中的应用最新进展。
Drugs. 1998 Jul;56(1):115-46. doi: 10.2165/00003495-199856010-00012.

引用本文的文献

1
Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands.荷兰实体器官移植中抗病毒耐药的巨细胞病毒感染。
J Antimicrob Chemother. 2019 Aug 1;74(8):2370-2376. doi: 10.1093/jac/dkz196.

本文引用的文献

1
Cytomegalovirus in solid organ transplantation.实体器官移植中的巨细胞病毒
Am J Transplant. 2013 Mar;13 Suppl 4:93-106. doi: 10.1111/ajt.12103.
2
Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.使用高剂量更昔洛韦治疗诱导耐更昔洛韦的实体器官移植患者的巨细胞病毒复制。
Transplantation. 2013 Apr 27;95(8):1015-20. doi: 10.1097/TP.0b013e31828555ac.
3
Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors.器官移植受者在转换为 mTOR 抑制剂后，巨细胞病毒感染对更昔洛韦耐药的治疗取得成功。
Transpl Int. 2012 Jul;25(7):e78-82. doi: 10.1111/j.1432-2277.2012.01489.x. Epub 2012 May 11.
4
High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy.D+R- 肾移植受者接受 preemptive 治疗后出现抗巨细胞病毒药物耐药的发生率较高。
Am J Transplant. 2012 Jan;12(1):202-9. doi: 10.1111/j.1600-6143.2011.03766.x. Epub 2011 Oct 3.
5
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials.在肾移植受者中，依维莫司与吗替麦考酚酯之间巨细胞病毒感染的发生率：三项临床试验的汇总分析。
Am J Transplant. 2011 Nov;11(11):2453-62. doi: 10.1111/j.1600-6143.2011.03674.x. Epub 2011 Aug 3.
6
Human cytomegalovirus and kidney transplantation: a clinician's update.人巨细胞病毒与肾移植：临床医生的最新知识更新。
Am J Kidney Dis. 2011 Jul;58(1):118-26. doi: 10.1053/j.ajkd.2011.04.010.
7
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.移植受者的耐药巨细胞病毒：法国队列研究。
J Antimicrob Chemother. 2010 Dec;65(12):2628-40. doi: 10.1093/jac/dkq368. Epub 2010 Oct 20.
8
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.国际实体器官移植中巨细胞病毒管理共识指南。
Transplantation. 2010 Apr 15;89(7):779-95. doi: 10.1097/TP.0b013e3181cee42f.
9
Cytomegalovirus in solid organ transplant recipients.实体器官移植受者中的巨细胞病毒
Am J Transplant. 2009 Dec;9 Suppl 4:S78-86. doi: 10.1111/j.1600-6143.2009.02897.x.
10
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.接受静脉注射更昔洛韦或口服缬更昔洛韦治疗的实体器官移植受者的巨细胞病毒耐药性
Antivir Ther. 2009;14(5):697-704.